Experienced in Cluster Headache

Dr. Gary Soucie

Family Medicine
Blackfoot Medical Center
1441 Parkway Dr, 
Blackfoot, ID 

Experienced in Cluster Headache
Blackfoot Medical Center
1441 Parkway Dr, 
Blackfoot, ID 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gary Soucie is a primary care provider, practicing in Family Medicine in Blackfoot, Idaho. Dr. Soucie is rated as an Experienced provider by MediFind in the treatment of Cluster Headache. His top areas of expertise are Maturity Onset Diabetes of the Young, Acute Kidney Failure, Visceromegaly, and Neonatal Onset Multisystem Inflammatory Disease.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in ID
Hospital Affiliations
Bingham Memorial Hospital
Mountain View Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Blackfoot Medical Center
1441 Parkway Dr, Blackfoot, ID 83221
Call: 208-785-2600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


12 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3502970
Study Phase: Phase 2
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

1 Total Publications

Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza.
Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza.
Journal: Open forum infectious diseases
Published: November 19, 2018
Similar Doctors
Advanced in Cluster Headache
Dr. Clay Prince
Family Medicine
Advanced in Cluster Headache
Dr. Clay Prince
Family Medicine

Complete Family Care PLLC

10 Madison Professional Park, 
Rexburg, ID 
 (52.5 miles away)
208-656-9467
Languages Spoken:
English
See accepted insurances

Clay Prince is a primary care provider, practicing in Family Medicine in Rexburg, Idaho. Dr. Prince is rated as an Advanced provider by MediFind in the treatment of Cluster Headache. His top areas of expertise are Cluster Headache, Neuralgia, Type 1 Diabetes (T1D), and Attention Deficit Hyperactivity Disorder (ADHD).

Advanced in Cluster Headache
Dr. Dean L. Williams
Family Medicine
Advanced in Cluster Headache
Dr. Dean L. Williams
Family Medicine
590 Gifford Ave, 
American Falls, ID 
 (37.7 miles away)
208-226-5147
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dean Williams is a primary care provider, practicing in Family Medicine in American Falls, Idaho. Dr. Williams is rated as an Advanced provider by MediFind in the treatment of Cluster Headache. His top areas of expertise are Cluster Headache, Tracheitis, Shingles, and Empyema. Dr. Williams is currently accepting new patients.

Experienced in Cluster Headache
Dr. Brady Martin
Family Medicine
Experienced in Cluster Headache
Dr. Brady Martin
Family Medicine

Office

850 Yellowstone Ave Ste B, 
Pocatello, ID 
 (20.1 miles away)
208-239-8066
Languages Spoken:
English
See accepted insurances

Brady Martin is a primary care provider, practicing in Family Medicine in Pocatello, Idaho. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Cluster Headache. His top areas of expertise are Attention Deficit Hyperactivity Disorder (ADHD), Insomnia, Maturity Onset Diabetes of the Young, and Hypertension.

VIEW MORE CLUSTER HEADACHE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Soucie's expertise for a condition
ConditionClose
      • Advanced
      • Acute Kidney Failure
        Dr. Soucie is
        Advanced
        . Learn about Acute Kidney Failure.
        See more Acute Kidney Failure experts
      • Chronic Cough
        Dr. Soucie is
        Advanced
        . Learn about Chronic Cough.
        See more Chronic Cough experts
      • Familial Mediterranean Fever
        Dr. Soucie is
        Advanced
        . Learn about Familial Mediterranean Fever.
        See more Familial Mediterranean Fever experts
      • Maturity Onset Diabetes of the Young
        Dr. Soucie is
        Advanced
        . Learn about Maturity Onset Diabetes of the Young.
        See more Maturity Onset Diabetes of the Young experts
      • Mevalonate Kinase Deficiency
        Dr. Soucie is
        Advanced
        . Learn about Mevalonate Kinase Deficiency.
        See more Mevalonate Kinase Deficiency experts
      • Neonatal Onset Multisystem Inflammatory Disease
        Dr. Soucie is
        Advanced
        . Learn about Neonatal Onset Multisystem Inflammatory Disease.
        See more Neonatal Onset Multisystem Inflammatory Disease experts
      View All 10 Advanced Conditions
      • Experienced
      • Abdominal Obesity Metabolic Syndrome
        Dr. Soucie is
        Experienced
        . Learn about Abdominal Obesity Metabolic Syndrome.
        See more Abdominal Obesity Metabolic Syndrome experts
      • Acute Cerebellar Ataxia
        Dr. Soucie is
        Experienced
        . Learn about Acute Cerebellar Ataxia.
        See more Acute Cerebellar Ataxia experts
      • Acute Cystitis
        Dr. Soucie is
        Experienced
        . Learn about Acute Cystitis.
        See more Acute Cystitis experts
      • Acute Interstitial Pneumonia
        Dr. Soucie is
        Experienced
        . Learn about Acute Interstitial Pneumonia.
        See more Acute Interstitial Pneumonia experts
      • Alzheimer's Disease
        Dr. Soucie is
        Experienced
        . Learn about Alzheimer's Disease.
        See more Alzheimer's Disease experts
      • Apoplexy
        Dr. Soucie is
        Experienced
        . Learn about Apoplexy.
        See more Apoplexy experts
      View All 109 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.